Quality is Everything

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

Oligo Analytics

Impurities, Sequence Fidelity, and Structural Variants in Nucleic Acid Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

In Vitro vs. In Vivo Potency Assays: Which Approach Is Best for Biopharmaceutical Product Characterization?

Pharma's Almanac

PAT

Real-Time Insight in Biologic Manufacturing: Why PAT Matters for Commercial Scale-Up

David Alvaro, Ph.D.

Pharma's Almanac

PAT

From Analytical Visibility to Real-Time Control in Biologics Purification

David Alvaro, Ph.D.

Pharma's Almanac

Advanced PAT

Deeper Process Visibility: Advanced Monitoring Technologies for Modern Biologics Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac

ADCs

Accelerating ADC Analytical Method Development Through Platform Innovation

Jaeook Kim, Ph.D.

Samsung Biologics

Aseptic Training

Human Factors in Aseptic Processing: Training, Behavior, and Risk Reduction

David Alvaro, Ph.D.

Pharma's Almanac

CCS

RABS or Isolators? Aligning Barrier Technology With Your Contamination Control Strategy

David Alvaro, Ph.D.

Pharma's Almanac

Autologous

A Release-by-Exception Model for Cell Therapy Quality Decisions

David Alvaro, Ph.D.

Pharma's Almanac

CGT Comparability

When Process Defines the Product: Managing Comparability in Cell and Gene Therapy Manufacturing

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac